Contraceptive News and Research

RSS

Appeals court temporarily blocks contraception mandate for Missouri business owner

A three-judge panel of the 8th U.S. Circuit Court of Appeals granted a preliminary injunction from the rule for Frank O'Brien and his company -- which is the fourth private business to secure such a temporary order.

1 Dec 2012

Sucampo receives supplement approval from FDA for AMITIZA

Sucampo Pharmaceuticals, Inc. today announced that the Company received a supplement approval from the U.S. Food and Drug Administration (FDA) that removes pregnancy "warnings and precautions" and clarifies information regarding the use of AMITIZA (lubiprostone) by pregnant and/or nursing women. In addition, the FDA expanded the labeling text of the Mechanism of Action section in the prescribing information for AMITIZA.

30 Nov 2012

Viewpoints: GOP attack on Medicare, Medicaid could hurt critical programs; Will says Obama is repeating his overreach on health care

Congressional Republicans are insisting that big cuts to Medicare and Medicaid be on the table in the negotiations over the so-called fiscal cliff and deficit reduction. That stance is largely a political move against two programs, which have been critical to the public welfare for the past half-century.

30 Nov 2012

Federal judge grants temporary injunction in Bible publisher's contraception rule challenge

In separate action, another judge ruled against Hobby Lobby's effort to be exempted from the contraception mandate.

21 Nov 2012

IUD insertion does not increase risk of pelvic inflammatory disease in women

The risk of developing pelvic inflammatory disease (PID) following insertion of an intrauterine device (IUD) is very low, whether or not women have been screened beforehand for gonorrhea and chlamydia, according to a joint study of nearly 60,000 women by researchers at the University of California, San Francisco (UCSF), and Kaiser Permanente Northern California Division of Research.

21 Nov 2012

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

19 Nov 2012

Family planning is 'global priority' to be recognized as human right

Improving access to family planning for the 222 million women who lack such services would bring many benefits, including helping to reduce maternal mortality and improve infant survival, UNFPA Executive Director Babatunde Osotimehin says in the Huffington Post's "Global Motherhood" blog, citing the recently released State of the World Population 2012 report.

16 Nov 2012

Strokes affecting people at younger ages

Michelle Nimmerrichter was only 20 years old when she suffered a stroke that left her in a coma and on a ventilator.

15 Nov 2012

Premenopausal use of hormonal contraceptives may improve women’s cognitive abilities

Premenopausal use of hormonal contraceptives may improve the cognitive abilities of women in midlife and for years afterward. This finding may have implications for prevention of declining cognitive function that occurs with advancing age and in diseases such as Alzheimer's.

8 Nov 2012

Keep momentum going to pursue innovation in contraceptive options

"It has been a banner year for media attention, political will and global resources on family planning and women's and girls' rights and empowerment," Ward Cates, president emeritus of FHI 360; Laneta Dorflinger, a scientist with FHI 360; and Kirsten Vogelsong, a senior program officer with the family planning division of the Bill & Melinda Gates Foundation, write in the Huffington Post "Global Motherhood" blog, noting the London Summit on Family Planning, World Contraception Day, and the inaugural International Day of the Girl Child.

6 Nov 2012

Low literacy strongly predicts childbearing among US teens

New research released today at the American Public Health Association's 140th Annual Meeting in San Francisco builds on previous knowledge about the link between teen pregnancy and social inequities internationally and suggests that, independent of other factors, low literacy in pre-teen girls strongly predicts childbearing among US teens.

1 Nov 2012

Blog examines PEPFAR restrictions regarding family planning

"Though the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) has been touted as one of our nation's most successful initiatives in global health (and certainly one of President George W. Bush's most positive legacies) it continues to miss the mark" when it comes to family planning, global gender specialist and freelance writer Jessica Mack writes in KPLU 88.5's "Humanosphere" blog.

29 Oct 2012

Austrian researchers receive $7.4 million award to verify new breast cancer pathways

The innovator's award recognises Josef Penninger's work in identifying a key molecular pathway how hormone replacement therapies and contraceptive pills can lead to breast cancer. His team provided the first genetic proof that a protein called RANKL is the master regulator of bone loss, which has contributed to the development of a novel drug already approved for the treatment of osteoporosis and skeletal related events in multiple cancers.

23 Oct 2012

New approach to prevention of breast cancer wins $7.4M award

A new approach to possible future prevention of breast cancer and slowing the spread of tumours has won Austrian researcher Josef Penninger, director of the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) in Vienna, a $7.4 million innovator's award to continue his research, from the USA's Congressionally Directed Medical Research Program.

22 Oct 2012

Drospirenone-containing birth control pills associated with increased risk of blood clots

A U.S. Food and Drug Administration-funded study led by the Kaiser Permanente Northern California Division of Research found an increased risk of arterial thrombotic events (ATE) and venous thromboembolic events (VTE) - commonly referred to as blockage of arteries and blood clots, respectively - associated with drospirenone-containing birth control pills compared to four low-dose estrogen combined hormonal contraceptives.

20 Oct 2012

Some Democratic congressional candidates make hay with little-noticed health law provision

Also in the headlines: a variety of reports on House and Senate races from across the country including some key House races in California, New York, Minnesota, Rhode Island, and Illinois; as well as Senate contests in Connecticut, Missouri, Wisconsin, Massachusetts and Pennsylvania.

20 Oct 2012

Breast-feeding associated with reduced risk of ER/PR-negative breast cancer

Breast-feeding reduces the risk for estrogen receptor-negative and progesterone receptor-negative breast cancer, according to a study conducted at Columbia University's Mailman School of Public Health.

19 Oct 2012

Simple strategies can make big difference in maternal mortality

Aissata Sall Yade, a communications assistant for the Senegal Urban Reproductive Health Initiative, part of IntraHealth International, writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog about Aissatou Dia Fall, a head midwife at Senegal's Gallo Dia Health Center in Yeumbeul, and her efforts to improve access to health care for women in the community.

19 Oct 2012

First Edition: October 19, 2012

Today's headlines include reports about how Medicare and women's health issues are playing in a number of House and Senate races.

19 Oct 2012

In second face-off, Obama and Romney rumble over a range of issues

News outlets examine how each candidate fared in Tuesday night's town-hall style debate. In general, many media sources note how little discussion surrounded issues related to Medicare and the health law.

19 Oct 2012

Contraceptive News and Research

Appeals court temporarily blocks contraception mandate for Missouri business owner

Sucampo receives supplement approval from FDA for AMITIZA

Viewpoints: GOP attack on Medicare, Medicaid could hurt critical programs; Will says Obama is repeating his overreach on health care

Federal judge grants temporary injunction in Bible publisher's contraception rule challenge

IUD insertion does not increase risk of pelvic inflammatory disease in women

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Family planning is 'global priority' to be recognized as human right

Strokes affecting people at younger ages

Premenopausal use of hormonal contraceptives may improve women’s cognitive abilities

Keep momentum going to pursue innovation in contraceptive options

Low literacy strongly predicts childbearing among US teens

Blog examines PEPFAR restrictions regarding family planning

Austrian researchers receive $7.4 million award to verify new breast cancer pathways

New approach to prevention of breast cancer wins $7.4M award

Drospirenone-containing birth control pills associated with increased risk of blood clots

Some Democratic congressional candidates make hay with little-noticed health law provision

Breast-feeding associated with reduced risk of ER/PR-negative breast cancer

Simple strategies can make big difference in maternal mortality

First Edition: October 19, 2012

In second face-off, Obama and Romney rumble over a range of issues

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News